Aspirin Tied To Lower Risk For Liver Cancer And Death From Liver Disease (November Post)

http://www.medicalnewstoday.com/articles/253407.php

A new study published on the journal of the national cancer institute shows that aspirin is associated with a risk reduction of liver cancer and death from chronic liver disease.

The study involved more than 300,000 people aged from 50 to 71, who reported their use of aspirin and monsteroidal anti-inflammatory drug (NSAID) for 12 years. The results showed that people who have been taking aspirin were 45% less likely to die from chronic liver disease and 41% were less likely to develop liver cancer (also called hepatocellular carcinoma HCC). The researchers stated that the aspirin, when taken exclusively or with other non-aspirin NSAIDs showed a consistent protective effect related to both HCC and incidence and CLD mortality, regardless of the frequency. The study seems to be very promising. If the results have been confirmed, the chronic liver disease and liver cancer could be prevented.

I chose this article because the liver cancer strikes nearly 29,000 Americans each year, and kills more than 20,000 people according to the national cancer institute. It is very encouraged to have such research seeking solutions for such a terrible disease and making people’s life easier.